Our research benefits the local, national and global health economy, resulting in novel treatment and intervention. The celebrated research scientists and clinicians who work here are focused on translating their findings from bench to bedside.
Covering obstetrics, gynaecology, neonatology and medical and surgical paediatrics, producing world-leading research addressing challenges surrounding women's and children's health.
Liverpool City Region has some of the poorest heart health in the country. We're targeting studies towards disease epidemiology, treatment and prevention.
Our scientists, engineers and clinicians are working collaboratively to uncover how vision is affected by disease and how we can treat vision loss.
We're advancing solutions to age-related diseases and conditions. Bringing together medical and veterinary clinicians, epidemiologists and biomedical scientists.
The Versus Arthritis Centre for Integrated Research into Musculoskeletal Ageing (CIMA) is a collaboration between researchers and clinicians at the University of Liverpool, University of Sheffield and Newcastle University. The Centre, funded by Versus Arthritis, was established in 2012.
The Centre has been formed as a strategic research platform, bringing together world-leading research and clinical specialists in cardiovascular biology and medicine.The Centre partners have allied their forces to tackle the stark issue of Cardiovascular health in the North West.
The Centre is a unique consortium delivering translational biomedical research in childhood arthritis and related musculoskeletal disorders. It is the UK’s first and only EATC dedicated to children and was established in 2014.
In collaboration with the UK Space Agency and Kayser Space Ltd, we're investigating skeletal muscle ageing in microgravity, with experiments to take place on the International Space Station.
We are collaborating with researchers at the University of Hull and University of Leeds to investigate the potential for computer models to realise replacement, reduction and refinement of animal use in musculoskeletal research.
Juvenile idiopathic arthritis (JIA) affects approximately 10,000 UK children. JIA-associated uveitis can cause partial or complete sight loss. Until now, standard treatments have significant side effects and 50% of cases may be unresponsive.
Our local and global partnerships provide vital support to our research activity.
